Cadre Holdings Inc Revenue Growth Rates (CDRE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cadre Holdings inc   (NYSE: CDRE)
 

CDRE's Revenue Growth by Quarter and Year

Cadre Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDRE Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 207.13
1st Quarter March 155.17
FY 362.30

CDREs Annual Revenue
Cadre Holdings Inc 's Revenue in the fiscal year 2025 $ 609.63 millions
Cadre Holdings Inc 's Revenue in the fiscal year 2024 $ 567.48 millions
Cadre Holdings Inc 's Revenue in the fiscal year 2023 $ 481.73 millions
Cadre Holdings Inc 's Revenue in the fiscal year 2022 $ 457.84 millions
Cadre Holdings Inc 's Revenue in the fiscal year 2021 $ 427.29 millions




CDRE Revenue second quarter 2026 Y/Y Growth Comment
Cadre Holdings inc achieved in the second quarter 2026, above Company average Revenue growth of 32.56% year on year, to $ 207.13 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 144 other companies have achieved higher Revenue growth. While Cadre Holdings Inc ' s Revenue rise of 32.56% ranks overall at the positon no. 2765 in the second quarter 2026.


CDRE Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -4.18 % 41.2 % 0.79 %
3rd Quarter September - 42.75 % -12.5 % 11.7 %
2nd Quarter June 32.56 % 8.27 % 19.51 % 2.13 %
1st Quarter March 20.17 % -6.18 % 23.16 % 7.03 %
FY   - 7.53 % 17.69 % -

Financial Statements
Cadre Holdings Inc 's second quarter 2026 Revenue $ 207.13 millions CDRE's Income Statement
Cadre Holdings Inc 's second quarter 2025 Revenue $ 156.25 millions Quarterly CDRE's Income Statement


CDRE Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 8.35 % 61.42 % 0.02 %
3rd Quarter September - -0.4 % -24.45 % 3.19 %
2nd Quarter June 33.48 % 21 % 4.85 % 8.05 %
1st Quarter March -7.98 % -26.62 % 10.43 % -9.62 %
FY (Year on Year)   - 7.53 % 17.69 % -


Back to CDRE Growth rate Comparisons >> Back to CDRE Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #145
Healthcare Sector #390
Overall #2765

Revenue Y/Y Growth Statistics
High Average Low
19.67 % 5.41 % -32.54 %
(Sep 30 2025)   (Jun 30 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #145
Healthcare Sector #390
Overall #2765
Revenue Y/Y Growth Statistics
High Average Low
19.67 % 5.41 % -32.54 %
(Sep 30 2025)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Cadre Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
182.69 % 9.36 % -63.02 %
(Dec 31 2020)  


CDRE's II. Quarter Q/Q Revenue Comment
Cadre Holdings inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 33.48%, to $ 207.13 millions, from $155.17 millions in the first quarter.
CDRE is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Cadre Holdings Inc 's Revenue growth quarter on quarter, overall rank is 339.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #79
Overall #339
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #79
Overall #339
Revenue Q/Q Growth Statistics
High Average Low
182.69 % 9.36 % -63.02 %
(Dec 31 2020)  


CDRE's II. Quarter Q/Q Revenue Comment
Cadre Holdings inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 33.48%, to $ 207.13 millions, from $155.17 millions in the first quarter.
CDRE is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Cadre Holdings Inc 's Revenue growth quarter on quarter, overall rank is 339.


Cadre Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 686.54 $ 635.66 $ 609.63 $ 616.99 $ 570.38
Y / Y Revenue Growth (TTM) 20.37 % 13.83 % 7.53 % 19.67 % 7.38 %
Year on Year Revenue Growth Overall Ranking # 1501 # 705 # 478 # 1428 # 1028
Seqeuential Revenue Change (TTM) 8 % 4.27 % -1.19 % 8.17 % 2.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 2765 # 2091 # 626 # 2191 # 1327


Cumulative Revenue growth Comment
Cadre Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 20.37% year on year, to $ 687 millions if the fiscal year would have ended in Jun 30 2026.
Cadre Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 5.41% and higher than 13.83% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 8 % from $635.66 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 5.41%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 8 % increase from $635.66 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 251 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 705 to 1501.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 145
Healthcare Sector # 252
Overall # 1501

Revenue TTM Y/Y Growth Statistics
High Average Low
19.67 %
 5.41 %
-32.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 145
Sector # 390
S&P 500 # 2765
Cumulative Revenue growth Comment
Cadre Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 20.37% year on year, to $ 687 millions if the fiscal year would have ended in Jun 30 2026.
Cadre Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 5.41% and higher than 13.83% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 8 % from $635.66 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 5.41%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 8 % increase from $635.66 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 251 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 705 to 1501.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 145
Healthcare Sector # 252
Overall # 1501

Revenue TTM Y/Y Growth Statistics
High Average Low
19.67 %
5.41 %
-32.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 145
Sector # 390
S&P 500 # 2765




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CDRE's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions
Vyne Therapeutics Inc 40.58%$ 40.580 millions
Qhslab Inc 39.98%$ 39.978 millions
Coherus Oncology inc 39.53%$ 39.526 millions
Neurocrine Biosciences Inc 39.49%$ 39.491 millions
Ss Innovations International Inc39.39%$ 39.393 millions
Assembly Biosciences Inc 38.94%$ 38.936 millions
Edap Tms Sa38.85%$ 38.847 millions
Picard Medical Inc 38.62%$ 38.620 millions
Hims and Hers Health Inc 38.41%$ 38.409 millions
Aquestive Therapeutics Inc 38.15%$ 38.149 millions
Mirum Pharmaceuticals Inc 37.92%$ 37.922 millions
Natera Inc 37.71%$ 37.715 millions


About Cadre Holdings Inc Revenue Growth Rates (CDRE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cadre Holdings Inc (CIK 1860543).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-091151
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cadre Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.